Wittenberger Michael D, Hagerman Randi J, Sherman Stephanie L, McConkie-Rosell Allyn, Welt Corrine K, Rebar Robert W, Corrigan Emily C, Simpson Joe Leigh, Nelson Lawrence M
Intramural Research Program, Section on Women's Health Research, Developmental Endocrinology Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892-1103, USA.
Fertil Steril. 2007 Mar;87(3):456-65. doi: 10.1016/j.fertnstert.2006.09.004. Epub 2006 Oct 30.
To update clinicians on the reproductive implications of premutations in FMR1 (fragile X mental retardation 1). Fragile X syndrome, a cause of mental retardation and autism, is due to a full mutation (>200 CGG repeats). Initially, individuals who carried the premutation (defined as more than 55 but less than 200 CGG repeats) were not considered at risk for any clinical disorders. It is now recognized that this was incorrect, specifically with respect to female reproduction.
Literature review and consensus building at two multidisciplinary scientific workshops.
CONCLUSION(S): Convincing evidence now relates the FMR1 premutation to altered ovarian function and loss of fertility. An FMR1 mRNA gain-of-function toxicity may underlie this altered ovarian function. There are major gaps in knowledge regarding the natural history of the altered ovarian function in women who carry the FMR1 premutation, making counseling about reproductive plans a challenge. Women with premature ovarian failure are at increased risk of having an FMR1 premutation and should be informed of the availability of fragile X testing. Specialists in reproductive medicine can provide a supportive environment in which to explain the implications of FMR1 premutation testing, facilitate access to testing, and make appropriate referral to genetic counselors.
向临床医生介绍FMR1(脆性X智力低下1基因)前突变对生殖的影响。脆性X综合征是智力低下和自闭症的一个病因,由完全突变(>200个CGG重复序列)引起。最初,携带前突变(定义为超过55个但少于200个CGG重复序列)的个体未被认为有患任何临床疾病的风险。现在人们认识到这种观点是错误的,特别是在女性生殖方面。
在两次多学科科学研讨会上进行文献综述并达成共识。
有令人信服的证据表明FMR1前突变与卵巢功能改变和生育力丧失有关。FMR1 mRNA功能获得性毒性可能是这种卵巢功能改变的基础。对于携带FMR1前突变的女性,其卵巢功能改变的自然史方面存在重大知识空白,这使得对生殖计划的咨询成为一项挑战。卵巢早衰的女性携带FMR1前突变的风险增加,应告知她们可进行脆性X检测。生殖医学专家可以提供一个支持性环境,在其中解释FMR1前突变检测的意义,便于进行检测,并适当地转诊给遗传咨询师。